BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25526090)

  • 1. Autophagy inhibits oxidative stress and tumor suppressors to exert its dual effect on hepatocarcinogenesis.
    Tian Y; Kuo CF; Sir D; Wang L; Govindarajan S; Petrovic LM; Ou JH
    Cell Death Differ; 2015 Jun; 22(6):1025-34. PubMed ID: 25526090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insight into the role of autophagy in tumorigenesis.
    Tian Y; Wang L; Ou JJ
    Cell Stress; 2017 Dec; 1(3):136-138. PubMed ID: 31225443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
    Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
    Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of ROS-induced autophagy in hepatocellular carcinoma.
    Yuan X; Wang B; Yang L; Zhang Y
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):306-312. PubMed ID: 29544680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis.
    Zhang W; Hou J; Wang X; Jiang R; Yin Y; Ji J; Deng L; Huang X; Wang K; Sun B
    Oncotarget; 2015 Apr; 6(11):9420-33. PubMed ID: 25826083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.
    Ding ZB; Hui B; Shi YH; Zhou J; Peng YF; Gu CY; Yang H; Shi GM; Ke AW; Wang XY; Song K; Dai Z; Shen YH; Fan J
    Clin Cancer Res; 2011 Oct; 17(19):6229-38. PubMed ID: 21825039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma.
    Guo W; Zhao Y; Zhang Z; Tan N; Zhao F; Ge C; Liang L; Jia D; Chen T; Yao M; Li J; He X
    Cancer Lett; 2011 Dec; 312(1):55-61. PubMed ID: 21906871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression.
    Hao PP; Li H; Lee MJ; Wang YP; Kim JH; Yu GR; Lee SY; Leem SH; Jang KY; Kim DG
    J Hepatol; 2015 Jun; 62(6):1278-86. PubMed ID: 25617504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the Mitochondrial Apoptotic Pathway Produces Reactive Oxygen Species and Oxidative Damage in Hepatocytes That Contribute to Liver Tumorigenesis.
    Hikita H; Kodama T; Tanaka S; Saito Y; Nozaki Y; Nakabori T; Shimizu S; Hayashi Y; Li W; Shigekawa M; Sakamori R; Miyagi T; Hiramatsu N; Tatsumi T; Takehara T
    Cancer Prev Res (Phila); 2015 Aug; 8(8):693-701. PubMed ID: 26038117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKCλ/ι Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression.
    Kudo Y; Sugimoto M; Arias E; Kasashima H; Cordes T; Linares JF; Duran A; Nakanishi Y; Nakanishi N; L'Hermitte A; Campos A; Senni N; Rooslid T; Roberts LR; Cuervo AM; Metallo CM; Karin M; Diaz-Meco MT; Moscat J
    Cancer Cell; 2020 Aug; 38(2):247-262.e11. PubMed ID: 32589943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma.
    Ma WL; Hsu CL; Wu MH; Wu CT; Wu CC; Lai JJ; Jou YS; Chen CW; Yeh S; Chang C
    Gastroenterology; 2008 Sep; 135(3):947-55, 955.e1-5. PubMed ID: 18639551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
    Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW
    Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation.
    Chen CC; Kim KH; Lau LF
    Oncogene; 2016 Mar; 35(10):1314-23. PubMed ID: 26028023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of Diethylnitrosamine-Initiated and Phenobarbital-Promoted Hepatocarcinogenesis in Rats by Sulfated Polysaccharides and Aqueous Extract of Ulva lactuca.
    Hussein UK; Mahmoud HM; Farrag AG; Bishayee A
    Integr Cancer Ther; 2015 Nov; 14(6):525-45. PubMed ID: 26130745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress in carcinogenesis. Correlation between lipid peroxidation and induction of preneoplastic lesions in rat hepatocarcinogenesis.
    Sánchez-Pérez Y; Carrasco-Legleu C; García-Cuellar C; Pérez-Carreón J; Hernández-García S; Salcido-Neyoy M; Alemán-Lazarini L; Villa-Treviño S
    Cancer Lett; 2005 Jan; 217(1):25-32. PubMed ID: 15596293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetramethylpyrazine (TMP) exerts antitumor effects by inducing apoptosis and autophagy in hepatocellular carcinoma.
    Cao J; Miao Q; Miao S; Bi L; Zhang S; Yang Q; Zhou X; Zhang M; Xie Y; Zhang J; Wang S
    Int Immunopharmacol; 2015 May; 26(1):212-20. PubMed ID: 25841319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis.
    Moriya K; Nakagawa K; Santa T; Shintani Y; Fujie H; Miyoshi H; Tsutsumi T; Miyazawa T; Ishibashi K; Horie T; Imai K; Todoroki T; Kimura S; Koike K
    Cancer Res; 2001 Jun; 61(11):4365-70. PubMed ID: 11389061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does oxidative stress participate in the development of hepatocellular carcinoma?
    Sasaki Y
    J Gastroenterol; 2006 Dec; 41(12):1135-48. PubMed ID: 17287893
    [No Abstract]   [Full Text] [Related]  

  • 20. The correlation of hepatitis B virus pre-S mutation with cellular oxidative DNA damage in hepatocellular carcinoma.
    Gwak GY; Lee DH; Moon TG; Choi MS; Lee JH; Koh KC; Paik SW; Park CK; Joh JW; Yoo BC
    Hepatogastroenterology; 2008; 55(88):2028-32. PubMed ID: 19260471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.